Baird Financial Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Buy |
3,865
+1
| +0% | +$64 | ﹤0.01% | 1649 |
|
|
2025
Q1 | $245K | Hold |
3,864
| – | – | ﹤0.01% | 1632 |
|
|
2024
Q4 | $257K | Hold |
3,864
| – | – | ﹤0.01% | 1606 |
|
|
2024
Q3 | $270K | Hold |
3,864
| – | – | ﹤0.01% | 1571 |
|
|
2024
Q2 | $250K | Buy |
3,864
+280
| +8% | +$18.1K | ﹤0.01% | 1612 |
|
|
2024
Q1 | $232K | Buy |
3,584
+309
| +9% | +$20K | ﹤0.01% | 1631 |
|
|
2023
Q4 | $216K | Buy |
+3,275
| New | +$216K | ﹤0.01% | 1622 |
|
|
2022
Q1 | – | Sell |
-3,000
| Closed | -$214K | – | 1902 |
|
|
2021
Q4 | $214K | Hold |
3,000
| – | – | ﹤0.01% | 1799 |
|
|
2021
Q3 | $225K | Hold |
3,000
| – | – | ﹤0.01% | 1768 |
|
|
2021
Q2 | $232K | Sell |
3,000
-12
| -0.4% | -$928 | ﹤0.01% | 1648 |
|
|
2021
Q1 | $222K | Hold |
3,012
| – | – | ﹤0.01% | 1613 |
|
|
2020
Q4 | $211K | Buy |
+3,012
| New | +$211K | ﹤0.01% | 1496 |
|
|
2020
Q3 | – | Sell |
-3,613
| Closed | -$211K | – | 1551 |
|
|
2020
Q2 | $211K | Buy |
+3,613
| New | +$211K | ﹤0.01% | 1405 |
|
|
2020
Q1 | – | Sell |
-3,613
| Closed | -$202K | – | 1521 |
|
|
2019
Q4 | $202K | Buy |
+3,613
| New | +$202K | ﹤0.01% | 1459 |
|
|
2015
Q3 | – | Sell |
-5,158
| Closed | -$301K | – | 1301 |
|
|
2015
Q2 | $301K | Buy |
+5,158
| New | +$301K | ﹤0.01% | 1121 |
|